News | ARLG

ARLG joins forces with COMBACTE on a number of initiatives designed to fight drug-resistant infections
The U.S.-based Antibacterial Resistance Leadership Group (ARLG), part of the Duke Clinical Research Institute (DCRI) and the University Medical Center (UMC) Utrecht, the managing entity of the COMBACTE (Combatting Bacterial Resistance in Europe) consortium, will work together to solidify a comprehensive global community to combat the threat of antibiotic resistance around the world. “We at the ARLG have long admired the work being done by COMBACTE to increase the efficacy of antimicrobial drug development,” said Vance Fowler, MD, an investigator at the DCRI and co-principal investigator of the ARLG. “Combining our efforts will allow us to maximize the work we both do to stop the advancement of antibacterial resistance.” Read more
ARLG at ECCMID
Support your ARLG colleagues who will be presenting at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Amsterdam, Netherlands from April 13-16, 2019. Read more
Michael Woodworth, MD, MSc, receives the Southern Society for Clinical Investigation Research Scholar Award
Congratulations to Michael Woodworth, MD, MSc, for being selected as a recipient of the Southern Society for Clinical Investigation (SSCI) Research Scholar Award. This award provides funding for physician-scientists with innovative research projects related to internal medicine and its subspecialties. Dr. Woodworth will use the award to provide additional project funding for the ARLG ongoing ... Read more
Two ARLG PI-Initiated, Laboratory-Based Trials Reached Database Lock
ARLG Principal Investigators Ritu Banerjee, MD, PhD of Vanderbilt University and Audrey Schuetz, MD, MPH, D (ABMM) of Mayo Clinic have successfully led the RAPIDS-GN and DISK trials, respectively, to completion. The primary objective of RAPIDS-GN is to evaluate the impact of rapid identification and antimicrobial susceptibility testing (AST) on the time to first antibiotic modification ... Read more